Evidence map›Paper›PMID 18193085›Full record

ArticleOncogene2008

TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.

C Clybouw, B E L Mchichi, A Hadji, A Portier, M T Auffredou, D Arnoult, G Leca, A Vazquez

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

C ClybouwINSERM U542, Université Paris-Sud, Hôpital Paul Brousse, Villejuif, France.
B E L Mchichi
A Hadji
A Portier
M T Auffredou
D Arnoult
G Leca
A Vazquez
Hôpital Paul-Brousse · FRUniversité Paris-Sud · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we showed that the transforming growth factor beta (TGFbeta)-mediated apoptosis of Burkitt's lymphoma BL41 cells is dependent on the BH3-only protein Bim. In contrast to what has been observed with other cell types, TGFbeta activation did not promote Bim upregulation in BL41 cells, but instead resulted in Bim release from the mitochondria. Indeed, Bim levels were high in healthy BL41 cells, in which they dimerized with the Bcl-2-like protein Mcl-1 at the mitochondrial surface. In healthy and TGFbeta-activated BL41 cells, unlike in epithelial cells or hepatocytes, Bim did not associate with Bcl-2 or Bcl-xL. TGFbeta activation of BL41 cells triggered the p38-dependent activation of caspase-8, causing the cleavage of Mcl-1 and the transfer of Bim from the mitochondria to the cytoskeleton. In addition to mitochondrial activation, this relocation of Bim may facilitate the complete demise of a cell death that is beyond the commitment point to apoptosis and may represent a hallmark of the TGFbeta-mediated apoptosis of human lymphoma B cells.

Indexed as

ApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11bcl-X ProteinBlotting, WesternBurkitt LymphomaCaspase 8Cell ProliferationCells, CulturedCytoskeletonDimerizationEnzyme ActivationEpithelial CellsHepatocytesHumansImmunoprecipitationApoptosis Regulatory ProteinsBCL2L11 protein, humanBCL2L1 protein, humanBcl-2-Like Protein 11bcl-X ProteinCaspase 8Membrane ProteinsMyeloid Cell Leukemia Sequence 1 ProteinNeoplasm Proteinsp38 Mitogen-Activated Protein KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Recombinant ProteinsRNA, MessengerRNA, Small InterferingTransforming Growth Factor beta

Identifiers

PMID18193085
OpenAlexW2087120175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.